Vinodhini Vellore Mohanakrishnan

Vinodhini Vellore Mohanakrishnan

Auto-generated profile, based on publicly available information

Vinodhini Vellore Mohanakrishnan

Department of Biochemistry, SRM Medical College Hospital and Research Centre, Faculty of Medicine and Health Sciences, SRM Institute of Science and Technology, SRM Nagar, Kattankulathur, Chengalpattu 603203, Tamil Nadu, India

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2025 in Microplastics
Verified
Journal Article
Open access
PDF file
RSRooban Sivakumar
Rooban Sivakumar
AAArul Senghor Kadalangudi Aravaanan
Arul Senghor Kadalangudi Aravaanan
VMVinodhini Vellore Mohanakrishnan
Vinodhini Vellore Mohanakrishnan
JKJanardanan Subramonia Kumar
Janardanan Subramonia Kumar
Microplastics, synthetic polymer particles measuring less than 5 mm, have become a widespread environmental pollutant, raising concerns over their possible effects on human health. Growing evidence links MPs to vascular aging and cardiovascular disease beyond their ecological toxicity. Upon inhalation, ingestion, or skin contact, microplastics can traverse biological barriers, circulate systemically, and accumulate in vascular tissues. Experimental investigations indicate that MPs, especially polystyrene and polyethylene in nano- and micro-sized forms, induce oxidative stress, mitochondrial dysfunction, and chronic inflammation. These disruptions activate redox-sensitive signaling pathways, such as NF-κB and NLRP3 inflammasome, causing endothelial dysfunction, vascular smooth muscle modulation, and foam cell production, indicating early vascular aging. Animal models and in vitro studies have consistently shown endothelial activation, increased cytokine production, and changes in vascular tone after exposure to MPs. Initial human research has detected microplastics in blood, thrombi, and atherosclerotic plaques, which correlate with negative cardiovascular outcomes and systemic inflammation. Notably, recent research suggests that the gut microbiota and antioxidant systems may play a role in adaptive reactions, although these processes are still not fully understood. MP-induced vascular toxicity is covered in this interdisciplinary review, highlighting molecular pathways, experimental data, and translational gaps.

6 September 2022 in Indian Journal of Clinical Biochemistry
Verified
Journal Article
Closed access
PDF file
MSM. K. Nilofer Sagana
M. K. Nilofer Sagana
KSK. A. Arul Senghor
K. A. Arul Senghor
VVV. M. Vinodhini
V. M. Vinodhini
RPRenuka P
Renuka P

28 December 2022 in Medeniyet Medical Journal
Verified
Journal Article
Open access
DNDinesh Nath
Dinesh Nath
MSMeera Shivasekar
Meera Shivasekar
VVV. M. Vinodhini
V. M. Vinodhini
Smoking causes cardiovascular risk, which may alter the stability between the production and degradation of the extracellular matrix. Matrix metalloproteinase-9 (MMP-9) is a zinc-containing endopeptidase that degrades the extracellular matrix and is involved in tissue remodelling and several physiological processes. As a result, smoking-induced elevated serum MMP-9 levels, particularly at a younger age, raise the risk of coronary heart disease (CHD). Thus, this study aimed to determine the possible relationship between smoking-induced circulating MMP-9 and the risk of cardiovascular disease in young smokers. In this cross-sectional study, the patients were divided into three groups. Each group contains 120 study participants. Group one consisted of 120 healthy individuals with no physical and mental illness, group two consisted of 120 active smokers with a heart disease, and group three consisted of 120 active smokers with a heart disease and diabetes, who attended Sri Ramaswamy Memorial Hospital for cardiology checkup at the age of 20-55 years. The serum MMP-9, high-sensitivity C-reactive protein (hs-CRP), and apolipoprotein-E (APO-E) levels were analyzed using the ELISA method, and the lipid levels were measured enzymatically using AU480 automatic analyzer (Beckman Coulter). Compared with non-smokers, the study shows that the mean serum MMP-9, hs-CRP, and APO-E levels were significantly higher in smokers (p<0.001). A strong relationship was also found between MMP-9 and hs-CRP, APO-E, smoking load, and smoking intensity. A significant association was found between cigarette smoking with MMP-9, and relative exposure to circulating inflammation markers plays a potential role in the pathogenesis of CHD.

12 September 2023 in International Archives of Occupational and Environmental Health
Verified
Journal Article
Closed access
PDF file
MNMohanraj Nehru
Mohanraj Nehru
PSPrasanth Subramanian
Prasanth Subramanian
PRP. Rajapriya
P. Rajapriya
GVG. Vinothkumar
G. Vinothkumar
VVV. M. Vinodhini
V. M. Vinodhini
VPVenkataraman Prabhu
Venkataraman Prabhu

3 March 2025 in NeuroToxicology
Verified
Journal Article
Closed access
SAS. Aishwarya
S. Aishwarya
VVV.M. Vinodhini
V.M. Vinodhini
PRP. Renuka
P. Renuka
AMANURADHA M
ANURADHA M
RSR. Arul Saravanan
R. Arul Saravanan

29 August 2024 in Cureus
Verified
Journal Article
Open access
PDF file
ARAravindraj R
Aravindraj R
RPRenuka P
Renuka P
VVVinodhini Vm
Vinodhini Vm
MSMeenakshi Sundari Sn
Meenakshi Sundari Sn
Introduction The prevalence of obesity and related disorders is rapidly rising due to altered food habits, sedentary lifestyles and stress. Adipose tissue releases various hormones known as adipokines; one example is chemerin, which is primarily expressed by hepatocytes, adipocytes, and immune cells. Adipokine dysregulation in obesity initiates the cascade of inflammation and insulin resistance that leads to various metabolic disorders such as diabetes mellitus, metabolic syndrome (MS), and metabolic dysfunction-associated fatty liver disease (MAFLD). Aim The aim of our research is to determine serum chemerin levels in obese and non-obese individuals and to estimate the prevalence of MAFLD in obesity. Materials and methods This cross-sectional study was conducted at SRM Medical College Hospital & Research Centre, Tamil Nadu from August 2023 to December 2023. The study group comprised 45 obese and 45 non-obese individuals above 18 years of age. New MAFLD diagnostic criteria and FLI (Fatty Liver Index) formula were used to stratify the cohort. The Godin Leisure-Time Exercise questionnaire was used to assess physical activity levels. Visceral fat was assessed using a body composition analyzer. Student’s t-test and ANOVA were used to compare the difference in mean levels across the groups. Pearson’s correlation was used to correlate the analyzed parameters. Results Among our obese study participants, nearly 50% reported following a sedentary lifestyle. The prevalence of MAFLD in our obese study group was 44% whereas the prevalence of non-alcoholic fatty disease was found to be only 33%. Fasting plasma glucose (FPG), HbA1c, triglycerides (TG) and chemerin levels were found to vary significantly between the two groups. However, our study did not reveal the association of chemerin with MAFLD, BMI, or visceral fat in obesity. A significant difference in BMI, and visceral fat was observed across groups stratified by their physical activity levels assessed using the Godin leisure questionnaire. Conclusion Our study highlights the effect of physical activity on adipose tissue distribution and metabolic health and does not reveal any significant association of chemerin with MAFLD, BMI, or visceral fat in obesity. Nearly half of the studied obese individuals lead sedentary lifestyles, which highlights the importance of promoting physical activity in the prevention of obesity and related metabolic dysfunction. To validate these findings, future research should involve larger, diverse cohorts and include longitudinal data to track shifts in chemerin levels over time and their impact on metabolic health.